SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-05-007524
Filing Date
2005-03-14
Accepted
2005-03-14 17:18:16
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 v014136_10-k.htm 10-K 2239370
2 v014136_ex21-1.htm EX-21.1 4409
3 v014136_ex23-1.htm EX-23.1 9721
4 v014136_ex31-1.htm EX-31.1 18586
5 v014136_ex31-2.htm EX-31.2 18577
6 v014136_ex32-1.htm EX-32.1 7172
7 v014136_ex32-2.htm EX-32.2 7810
  Complete submission text file 0001144204-05-007524.txt   2307598
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30929 | Film No.: 05679213
SIC: 2834 Pharmaceutical Preparations